ABOUT
CELLTELLIGENCE

Celltelligence is a unique mix of industry experts, analysts, and academics dedicated to bringing deeper context and insight to the cell therapy market. Here’s why we’re different.

ABOUT
CELLTELLIGENCE

Celltelligence is a unique mix of industry experts, analysts, and academics dedicated to bringing deeper context and insight to the cell therapy market. Here’s why were different.

WHO WE ARE

Our team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

WHO WE ARE

Our team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.

WHY WE’RE DIFFERENT

Celltelligence isn’t just another newsletter or curated content blast. Our market intelligence is heavily researched, up-to-date, and deeply informed by our direct relationships with cell therapy stakeholders including KOLs. This provides our customers with an insider’s perspective on the market, helping you to create more accurate forecasts and quicker calculated decisions.

WHY WE’RE DIFFERENT

Celltelligence isn’t just another newsletter or curated content blast. Our market intelligence is heavily researched, up-to-date, and deeply informed by our direct relationships with cell therapy stakeholders including KOLs. This provides our customers with an insider’s perspective on the market, helping you to create more accurate forecasts and quicker calculated decisions.

HOW WE MAKE YOUR JOB EASIER

The Blast, Map, and Library are all designed for people who care about cell therapy and want better, easier options to leverage market insight. We tailor content to all relevant stakeholders – including industry professionals, academics, and both buy- and sell-side analysts. With Celltelligence, you’ll make it easier to uncover blindspots and stay on top of industry movement for your organization or your clients.

HOW WE MAKE YOUR JOB EASIER

The Blast, Map, and Library are all designed for people who care about cell therapy and want better, easier options to leverage market insight. We tailor content to all relevant stakeholders – including industry professionals, academics, and both buy- and sell-side analysts. With Celltelligence, you’ll make it easier to uncover blindspots and stay on top of industry movement for your organization or your clients.

MEET THE ‘TELLIGENCE IN OUR TEAM

Matthew Maryniak
Team Lead
  • Celltelligence Team Leader (2020 – Present)
  • Former Principal at IQVIA Consulting Group (8 years tenure)
  • Recognized industry expert in Pink Sheet, PM360, and journal article
  • MBA in Pharmaceutical Business, Univ of Sciences in PHL
Dafni Chondronasiou, PhD​
Content Contributor
  • Celltelligence contributor (2022 – Present)
  • 10+ years experience in basic and translational oncology and cellular plasticity in international academic institutes
  • PhD in Biosciences, Autonomous University of Madrid, Spain
  • MSc in Biomedical Sciences, University of Amsterdam, the Netherlands
  • BSc in Biology, Aristotle University of Thessaloniki, Greece (+6 months in University of Rennes 1, France)
Uxue Urdiroz, PhD
Content Contributor
  • Celltelligence contributor (2023 – Present)
  • 7+ years research experience in the molecular and cellular biology of cancer with special focus on metastasis and tumor cell metabolism
  • PhD in Biomedicine, University of Barcelona, Spain
  • MSc in Biomedical Research, University of Barcelona, Spain
  • BSc in Biomedical Sciences, University of Lleida, Spain (+6 months in University of Heidelberg, Germany)
Francesco Maria Affuso
Content Contributor
  • Celltelligence contributor (2022 – Present)
  • Research assistant – Stem Cell Aging lab at IDIBELL, Barcelona, Spain
  • MS in Medical Biotechnology, University of Bologna, Italy
  • BS in Biotechnology, University of Ferrara, Italy

MEET THE ‘TELLIGENCE IN OUR TEAM

Matthew Maryniak
Team Lead
  • Celltelligence Team Leader (2020 – Present)
  • Former Principal at IQVIA Consulting Group (8 years tenure)
  • Recognized industry expert in Pink Sheet, PM360, and journal article
  • MBA in Pharmaceutical Business, Univ of Sciences in PHL
Dafni Chondronasiou, PhD​
Content Contributor
  • Celltelligence contributor (2022 – Present)
  • 10+ years experience in basic and translational oncology and cellular plasticity in international academic institutes
  • PhD in Biosciences, Autonomous University of Madrid, Spain
  • MSc in Biomedical Sciences, University of Amsterdam, the Netherlands
  • BSc in Biology, Aristotle University of Thessaloniki, Greece (+6 months in University of Rennes 1, France)
Uxue Urdiroz, PhD
Content Contributor
  • Celltelligence contributor (2023 – Present)
  • 7+ years research experience in the molecular and cellular biology of cancer with special focus on metastasis and tumor cell metabolism
  • PhD in Biomedicine, University of Barcelona, Spain
  • MSc in Biomedical Research, University of Barcelona, Spain
  • BSc in Biomedical Sciences, University of Lleida, Spain (+6 months in University of Heidelberg, Germany)
Francesco Maria Affuso
Content Contributor
  • Celltelligence contributor (2022 – Present)
  • Research assistant – Stem Cell Aging lab at IDIBELL, Barcelona, Spain
  • MS in Medical Biotechnology, University of Bologna, Italy
  • BS in Biotechnology, University of Ferrara, Italy

START TODAY FOR FREE

Get contextualized, actionable insights on the cell therapy landscape and all its players delivered to your inbox weekly.

Copyright © 2024 Fenix Group International, LLC